Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Halozyme Therapeutic (HALO)

23.26   -0.34 (-1.44%) 06-04 16:00
Open: 23.35 Pre. Close: 23.6
High: 23.8 Low: 23.105
Volume: 1,445,007 Market Cap: 3,159M
Halozyme Therapeutics Inc is a biotechnology company. It is engaged in research on human enzymes that alter the extracellular matrix and tumor environment.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 23.829 - 23.977 23.977 - 24.083
Low: 22.748 - 22.933 22.933 - 23.064
Close: 23.017 - 23.288 23.288 - 23.479

Technical analysis

as of: 2020-06-04 4:32:05 PM
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 28.32     One year: 29.99
Support: Support1: 21.92    Support2: 18.24
Resistance: Resistance1: 24.24    Resistance2: 25.68
Pivot: 24.00
Moving Average: MA(5): 23.92     MA(20): 23.98
MA(100): 20.32     MA(250): 18.26
MACD: MACD(12,26): 0.53     Signal(9): 0.79
Stochastic oscillator: %K(14,3): 39.10     %D(3): 47.47
RSI: RSI(14): 49.92
52-week: High: 25.68  Low: 12.71  Change(%): 50.0
Average Vol(K): 3-Month: 165317  10-Days: 139391

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
HALO has closed above bottom band by 2.0%. Bollinger Bands are 60.5% narrower than normal. The narrow width of the bands suggests low volatility as compared to HALO's normal range. The bands have been in this narrow range for 14 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Thu, 04 Jun 2020
Halozyme Announces Janssen Receives European Marketing Authorization For Subcutaneous DARZALEX® Utilizing Halozyme's ENHANZE® Technology For The Treatment Of Patients With Multiple Myeloma - PRNewswire

Tue, 12 May 2020
Halozyme Therapeutics Inc (HALO) Q1 2020 Earnings Call Transcript - The Motley Fool

Thu, 14 May 2020
Halozyme To Receive $15 Million Milestone Payment From Janssen - PRNewswire

Fri, 05 Jun 2020
EC approval for subcutaneous Darzalex - The Pharma Letter

Wed, 13 May 2020
Barclays Sticks to Their Hold Rating for Halozyme Therapeutics - Yahoo Finance

Thu, 28 May 2020
Halozyme To Present At Upcoming Virtual Investor Conferences - Yahoo Finance

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 136
Shares Float (M) 127
% Held by Insiders 1.20
% Held by Institutions 101.78
Shares Short (K) 15,480
Shares Short P. Month (K) 13,990

Stock Financials

EPS -0.560
EPS Est This Year -0.130
EPS Est Next Year -0.790
Book Value (p.s.) 0.430
Profit Margin -48.75
Operating Margin -27.61
Return on Assets (ttm) -6.2
Return on Equity (ttm) -50.4
Qtrly Rev. Growth -55.5
Gross Profit (p.s.) 0.198
Sales Per Share 1.210
EBITDA (p.s.) -0.319
Qtrly Earnings Growth
Operating Cash Flow (M) -86
Levered Free Cash Flow (M) -33

Stock Valuations

PE Ratio -41.54
PEG Ratio
Price to Book value 54.09
Price to Sales 19.22
Price to Cash Flow -36.80

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.